Thompson Davis & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $40K | Buy |
800
+300
| +60% | +$15K | 0.09% | 238 |
|
|
2018
Q2 | $25K | Sell |
500
-200
| -29% | -$10K | 0.06% | 280 |
|
|
2018
Q1 | $34K | Buy |
700
+100
| +17% | +$4.86K | 0.09% | 227 |
|
|
2017
Q4 | $27K | Sell |
600
-584
| -49% | -$26.3K | 0.06% | 274 |
|
|
2017
Q3 | $60K | Sell |
1,184
-32
| -3% | -$1.62K | 0.11% | 199 |
|
|
2017
Q2 | $66K | Hold |
1,216
| – | – | 0.11% | 180 |
|
|
2017
Q1 | $64K | Hold |
1,216
| – | – | 0.09% | 202 |
|
|
2016
Q4 | $59K | Buy |
1,216
+228
| +23% | +$11.1K | 0.1% | 211 |
|
|
2016
Q3 | $53K | Sell |
988
-200
| -17% | -$10.7K | 0.09% | 222 |
|
|
2016
Q2 | $64K | Buy |
1,188
+68
| +6% | +$3.66K | 0.1% | 199 |
|
|
2016
Q1 | $57K | Buy |
1,120
+200
| +22% | +$10.2K | 0.08% | 218 |
|
|
2015
Q4 | $46K | Hold |
920
| – | – | 0.06% | 272 |
|
|
2015
Q3 | $44K | Buy |
920
+216
| +31% | +$10.3K | 0.06% | 285 |
|
|
2015
Q2 | $37K | Buy |
704
+24
| +4% | +$1.26K | 0.04% | 372 |
|
|
2015
Q1 | $39K | Sell |
680
-52
| -7% | -$2.98K | 0.05% | 346 |
|
|
2014
Q4 | $39K | Buy |
732
+320
| +78% | +$17K | 0.05% | 332 |
|
|
2014
Q3 | $24K | Buy |
+412
| New | +$24K | 0.03% | 422 |
|
|
2014
Q2 | – | Sell |
-200
| Closed | -$13K | – | 795 |
|
|
2014
Q1 | $13K | Buy |
+200
| New | +$13K | 0.02% | 447 |
|